+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of AL amyloidosis with blood stem cells autotransplantation in renal patients



Treatment of AL amyloidosis with blood stem cells autotransplantation in renal patients



Nephrology Dialysis Transplantation 14(9): A82, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 035980315

Download citation: RISBibTeXText


Related references

Randomized trial of G-CSF alone vs sequential interleukin-3 and G-CSF treatment to peripheralize progenitor cells for apheresis and blood stem cell autotransplantation in patients with advanced stage breast cancer. Blood 84(10 SUPPL 1): 108A, 1994

G-CSF vs GM-CSF primed bone marrow stem cells or peripheral blood stem cells for autotransplantation A randomized comparison of engraftment and relapse. Blood 88(10 SUPPL 1 PART 1-2): 395A, 1996

Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 9(4): 615-623, 1995

White blood cell lysis syndrome after autologous peripheral blood stem cell transplantation in the treatment of renal AL amyloidosis. Case report. Revista Medica de Chile 134(6): 763-766, 2006

Autotransplantation with Philadelphia negative peripheral blood stem cells mobilised with hydroxyurea and G-CSF achieves prolonged engraftment in patients with chronic myeloid leukaemia. British Journal of Haematology 97(SUPPL 1): 21, 1997

Kaposis sarcoma-associated herpesvirus is not detected in G-CSF mobilized blood stem cells from patients with AL amyloidosis. Blood 90(10 SUPPL 1 PART 1): 212A, Nov 15, 1997

G-CSF mobilization of blood stem cells followed by large-volume leukapheresis and CD34-selection in patients with AL amyloidosis. Blood 88(10 SUPPL 1 PART 1-2): 406A, 1996

The impact and risk factors of post conditioning renal insufficiency on patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 447A, 2002

Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. European Journal of Cardio-Thoracic Surgery 33(2): 257-262, 2007

The autotransplantation of hematopoietic stem cells from the peripheral blood. Terapevticheskii Arkhiv 62(7): 26-31, 1990

Utilization of peripheral blood stem cells in autotransplantation. Hematology/Oncology Clinics of North America 7(3): 535-545, 1993

Mobilization of peripheral blood hematopoietic stem cells by granulocyte-colony stimulating factor and plerixafor in patients with cardiac AL amyloidosis. Amyloid 22(4): 259-260, 2016

Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide. Bone Marrow Transplantation 4(5): 595-596, 1989

Renal autotransplantation for localized amyloidosis of the ureter. Journal of Urology 128(1): 119-121, 1982

Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells. Progress in Clinical and Biological Research 377: 297-308, 1992